A single-nucleotide polymorphism in a gene modulating glucocorticoid sensitivity is associated with the decline in total lung capacity after lung transplantation

Haruchika Yamamoto, Seiichiro Sugimoto, Shin Tanaka, Takeshi Kurosaki, Shinji Otani, Masaomi Yamane, Naruto Taira, Takahiro Oto, Shinichi Toyooka

Research output: Contribution to journalArticle

Abstract

Purpose: Glucocorticoids are used to prevent chronic lung allograft dysfunction (CLAD) after lung transplantation (LT). Our study was aimed at assessing the association between the glucocorticoid-induced transcript 1 gene (GLCCI1) variant, which modulates glucocorticoid sensitivity, and the postoperative lung function and development of CLAD after LT. Methods: A total of 71 recipients of LT were genotyped for the GLCCI1 variant (rs37972) and divided into three groups: the homozygous mutant allele (TT) group, the heterozygous mutant allele (CT) group, and the wild-type allele (CC) group. The results of pulmonary function tests were compared with the postoperative baseline values. Results: The total lung capacity (TLC) in the TT group was significantly lower than that in the CC group at 3 years after LT (P = 0.029). In the recipients of cadaveric LT, the TLC and forced expiratory volume in 1 s in the TT group were significantly lower than those in the CC groups, resulting in a significant worse CLAD-free survival at 3 years after LT (P = 0.016). Conclusion: The GLCCI1 variant was associated with a significant decrease of the TLC at 3 years after LT and the development of CLAD at 3 years, especially in patients undergoing cadaveric LT.

Original languageEnglish
JournalSurgery Today
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Total Lung Capacity
Lung Transplantation
Glucocorticoids
Single Nucleotide Polymorphism
Genes
Allografts
Lung
Alleles
Respiratory Function Tests
Forced Expiratory Volume
Survival

Keywords

  • Chronic lung allograft dysfunction
  • Glucocorticoid
  • Lung transplantation
  • Single-nucleotide polymorphism
  • Total lung capacity

ASJC Scopus subject areas

  • Surgery

Cite this

@article{7db888e05aad4e37a8c868bfbf618d24,
title = "A single-nucleotide polymorphism in a gene modulating glucocorticoid sensitivity is associated with the decline in total lung capacity after lung transplantation",
abstract = "Purpose: Glucocorticoids are used to prevent chronic lung allograft dysfunction (CLAD) after lung transplantation (LT). Our study was aimed at assessing the association between the glucocorticoid-induced transcript 1 gene (GLCCI1) variant, which modulates glucocorticoid sensitivity, and the postoperative lung function and development of CLAD after LT. Methods: A total of 71 recipients of LT were genotyped for the GLCCI1 variant (rs37972) and divided into three groups: the homozygous mutant allele (TT) group, the heterozygous mutant allele (CT) group, and the wild-type allele (CC) group. The results of pulmonary function tests were compared with the postoperative baseline values. Results: The total lung capacity (TLC) in the TT group was significantly lower than that in the CC group at 3 years after LT (P = 0.029). In the recipients of cadaveric LT, the TLC and forced expiratory volume in 1 s in the TT group were significantly lower than those in the CC groups, resulting in a significant worse CLAD-free survival at 3 years after LT (P = 0.016). Conclusion: The GLCCI1 variant was associated with a significant decrease of the TLC at 3 years after LT and the development of CLAD at 3 years, especially in patients undergoing cadaveric LT.",
keywords = "Chronic lung allograft dysfunction, Glucocorticoid, Lung transplantation, Single-nucleotide polymorphism, Total lung capacity",
author = "Haruchika Yamamoto and Seiichiro Sugimoto and Shin Tanaka and Takeshi Kurosaki and Shinji Otani and Masaomi Yamane and Naruto Taira and Takahiro Oto and Shinichi Toyooka",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s00595-018-1717-9",
language = "English",
journal = "Japanese Journal of Surgery",
issn = "0941-1291",
publisher = "Springer Japan",

}

TY - JOUR

T1 - A single-nucleotide polymorphism in a gene modulating glucocorticoid sensitivity is associated with the decline in total lung capacity after lung transplantation

AU - Yamamoto, Haruchika

AU - Sugimoto, Seiichiro

AU - Tanaka, Shin

AU - Kurosaki, Takeshi

AU - Otani, Shinji

AU - Yamane, Masaomi

AU - Taira, Naruto

AU - Oto, Takahiro

AU - Toyooka, Shinichi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: Glucocorticoids are used to prevent chronic lung allograft dysfunction (CLAD) after lung transplantation (LT). Our study was aimed at assessing the association between the glucocorticoid-induced transcript 1 gene (GLCCI1) variant, which modulates glucocorticoid sensitivity, and the postoperative lung function and development of CLAD after LT. Methods: A total of 71 recipients of LT were genotyped for the GLCCI1 variant (rs37972) and divided into three groups: the homozygous mutant allele (TT) group, the heterozygous mutant allele (CT) group, and the wild-type allele (CC) group. The results of pulmonary function tests were compared with the postoperative baseline values. Results: The total lung capacity (TLC) in the TT group was significantly lower than that in the CC group at 3 years after LT (P = 0.029). In the recipients of cadaveric LT, the TLC and forced expiratory volume in 1 s in the TT group were significantly lower than those in the CC groups, resulting in a significant worse CLAD-free survival at 3 years after LT (P = 0.016). Conclusion: The GLCCI1 variant was associated with a significant decrease of the TLC at 3 years after LT and the development of CLAD at 3 years, especially in patients undergoing cadaveric LT.

AB - Purpose: Glucocorticoids are used to prevent chronic lung allograft dysfunction (CLAD) after lung transplantation (LT). Our study was aimed at assessing the association between the glucocorticoid-induced transcript 1 gene (GLCCI1) variant, which modulates glucocorticoid sensitivity, and the postoperative lung function and development of CLAD after LT. Methods: A total of 71 recipients of LT were genotyped for the GLCCI1 variant (rs37972) and divided into three groups: the homozygous mutant allele (TT) group, the heterozygous mutant allele (CT) group, and the wild-type allele (CC) group. The results of pulmonary function tests were compared with the postoperative baseline values. Results: The total lung capacity (TLC) in the TT group was significantly lower than that in the CC group at 3 years after LT (P = 0.029). In the recipients of cadaveric LT, the TLC and forced expiratory volume in 1 s in the TT group were significantly lower than those in the CC groups, resulting in a significant worse CLAD-free survival at 3 years after LT (P = 0.016). Conclusion: The GLCCI1 variant was associated with a significant decrease of the TLC at 3 years after LT and the development of CLAD at 3 years, especially in patients undergoing cadaveric LT.

KW - Chronic lung allograft dysfunction

KW - Glucocorticoid

KW - Lung transplantation

KW - Single-nucleotide polymorphism

KW - Total lung capacity

UR - http://www.scopus.com/inward/record.url?scp=85053491600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053491600&partnerID=8YFLogxK

U2 - 10.1007/s00595-018-1717-9

DO - 10.1007/s00595-018-1717-9

M3 - Article

C2 - 30229311

AN - SCOPUS:85053491600

JO - Japanese Journal of Surgery

JF - Japanese Journal of Surgery

SN - 0941-1291

ER -